peptyd miedziowy ghk cu NL-GHK-Cu™ (TETRAPEPTYD + CU) Peptyd miedziowy GHK-Cu 50 mg

An animal with increased or decreased resistance to a lateral push after ischemia was assigned a + or score, respectively (Gaur et al., 2009), and the percentage of rats showing resistance to a lateral push was recorded

The method of any one of embodiments 118-137, wherein the composition comprises between about 0.0001% to about 20% by weight of the therapeutic agent, about 0.0001% to about 15% by weight of the therapeutic agent, about 0.0001% to about 10% by weight of the therapeutic agent, about 0.0001% to about 5% by weight of the therapeutic agent therapeutic agent, or about 0.0001% to about 1% by weight of the therapeutic agent

Uversky, 2019;Martin and Holehouse, 2020

This treatment helps combat fatigue, improve focus, and support healthy red blood cell production